Skip to main content
. 2013 Jul;154(7):1038–1044. doi: 10.1016/j.pain.2013.03.011

Table 1.

Baseline characteristics by opioid prescription status (n = 715).

No opioid prescription Opioid prescription group (morphine equivalent dose)
t test/χ2
P value
None Low Medium High
Baseline characteristic n = 481(67.3%) n = 152(21.3%) n = 57(8.0%) n = 25(3.5%)
Age (years), mean (SD) 45.77 (9.87) 46.27 (9.36) 44.07 (10.69) 47.64 (9.39) .891
Gender, female 56.1% 67.1% 73.7% 76.0% <.001
Socioeconomic status
Professional/manager
33.7% 26.3% 26.4% 24.0% .022
Employment status
Employed and working as usual
63.4% 40.8% 26.3% 24.0% <.001
Duration of current episode of lower back pain
>3 months
34.3% 34.9% 43.9% 36.0% .450
Leg pain below the knee 32.0% 39.5% 49.1% 68.0% .001
Usual pain intensity
Numerical rating scale (0–10), mean (SD)
4.28 (2.49) 5.43 (2.66) 6.21 (2.25) 7.08 (2.31) <.001
Disability
Roland-Morris Disability Questionnaire (0–24), mean (SD)
7.37 (5.18) 10.74 (5.99) 13.05 (5.99) 15.56 (5.21) <.001
Distress
Hospital Anxiety and Depression
Questionnaire score ⩾8 for anxiety and depression
26.2% 36.8% 50.9% 56.0% <.001
Fear of movement
Tampa Scale of Kinesiophobia (17–68), mean (SD)
38.70 (6.83) 40.32 (6.78) 41.01 (6.72) 42.97 (7.12) <.001
Self efficacy
Pain Self-Efficacy Questionnaire (0–60), mean (SD)
41.60 (12.79) 34.05 (14.96) 27.97 (15.26) 26.84 (13.23) <.001
Coping style
 CSQ—diversion (0–36), mean (SD) 14.98 (8.15) 16.53 (6.50) 16.31 (6.59) 18.92 (6.65) .008
 CSQ—catastrophizing (0–36), mean (SD) 8.64 (6.93) 11.05 (8.35) 13.31 (9.23) 16.5 (8.98) <.001
 CSQ—reinterpretation (0–36), mean (SD) 7.63 (6.98) 7.60 (6.49) 6.94 (6.50) 7.50 (5.20) .714
 CSQ—cognitive coping (0–30), mean (SD) 17.56 (6.12) 15.84 (6.50) 15.70 (6.59) 15.48 (5.87) <.001
Nonsteroidal anti-inflammatory drug
Prescribed at baseline
32.0% 49.3% 43.9% 48.0% <.001
Comorbidity
Number of prescribed nonanalgesic medications, mean (SD)
0.88 (1.64) 2.05 (3.12) 2.35 (3.75) 3.28 (3.54) <.001

CSQ = Coping Strategies Questionnaire.

Comparison of any opioid prescription at baseline versus no opioid prescription at baseline.